Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (2012) (ISBN 0309225493) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (2008) (ISBN 0309120888) Theresa Wizeman, Sally Robinson, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Preventing Medication Errors: Quality Chasm Series (2007) (ISBN 0309101476) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• Safe Medical Devices for Children (2005) (ISBN 0309096316) Marilyn J. Field and Hugh Tilson, Editors, Committee on Postmarket Surveillance of Pediatric Medical Devices


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (2011) (ISBN 0309212421) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector (1995) (ISBN 0309052440) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary (2009) (ISBN 0309130441) Robert Giffin and Sally Robinson, Rapporteurs; Institute of Medicine


• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (2012) (ISBN 0309261163) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Scientific Standards for Studies on Modified Risk Tobacco Products (2012) (ISBN 0309223989) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Orphans and Incentives: Developing Technology to Address Emerging Infections (1997) (ISBN 0309059410) Polly F. Harrison and Joshua Lederberg, Editors; Forum on Emerging Infections, Institute of Medicine


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010) (ISBN 0309151295) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Animal Models for Assessing Countermeasures to Bioterrorism Agents (2011) (ISBN 0309219094) Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents; National Research Council


• Extending the Spectrum of Precompetitive Collaboration in Oncology Research: Workshop Summary (2010) (ISBN 0309156548) Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; Institute of Medicine